2 ms·
It's disappointing that the official US NIH COVID-19 treatment guidelines still don't recommend fluvoxamine. The evidence seems pretty solid now, and the risks
by nradov 5y ago
It's disappointing that the official US NIH COVID-19 treatment guidelines still don't recommend fluvoxamine. The evidence seems pretty solid now, and the risks of taking it for just a few days are very low for most patients
https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/fluvoxamine/ https://www.covid19treatmentguidelines.nih.gov/therapies/imm...
Anecdotal reports indicate that US physicians are already frequently prescribing it off label with good results.